CA Patent

CA2735934C — Method of treatment of attention deficit/hyperactivity disorder (adhd)

Assigned to Supernus Pharmaceuticals Inc · Expires 2014-01-07 · 12y expired

What this patent protects

The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or no-radrenergic reuptake transporters and monoamine receptor activity.

USPTO Abstract

The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or no-radrenergic reuptake transporters and monoamine receptor activity.

Drugs covered by this patent

Patent Metadata

Patent number
CA2735934C
Jurisdiction
CA
Classification
—
Expires
2014-01-07
Drug substance claim
No
Drug product claim
No
Assignee
Supernus Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.